The terms of the five-year supply agreement were not disclosed.
AMRI chairman, president and chief executive officer Thomas E. D’Ambra said, "Our partnership lays the groundwork for AMRI to be considered by Shire for future development and manufacturing opportunities."
AMRI offers fully integrated drug discovery, development, and manufacturing services.